| Year |
Citation |
Score |
| 2022 |
Behling E, Farhat LC, Landeros-Weisenberger A, Bloch MH. Meta-Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic Disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 37: 684-693. PMID 35191552 DOI: 10.1002/mds.28957 |
0.303 |
|
| 2021 |
Farhat LC, Vattimo EFQ, Ramakrishnan D, Levine JLS, Johnson JA, Artukoglu BB, Landeros-Weisenberger A, Asbahr FR, Cepeda SL, Comer JS, Fatori D, Franklin ME, Freeman JB, Geller DA, Grant PJ, ... ... Bloch MH, et al. Systematic Review and Meta-Analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 34597773 DOI: 10.1016/j.jaac.2021.05.027 |
0.325 |
|
| 2021 |
Nasir M, Li F, Courley S, Olten B, Bloch MH. Meta-Analysis: Pediatric Placebo Response in Depression Trials Does Not Replicate in Anxiety and Obsessive-Compulsive Disorder Trials. Journal of Child and Adolescent Psychopharmacology. PMID 34558984 DOI: 10.1089/cap.2021.0030 |
0.327 |
|
| 2020 |
Szejko N, Lombroso A, Bloch MH, Landeros-Weisenberger A, Leckman JF. Refractory Gilles de la Tourette Syndrome-Many Pieces That Define the Puzzle. Frontiers in Neurology. 11: 589511. PMID 33391155 DOI: 10.3389/fneur.2020.589511 |
0.345 |
|
| 2020 |
Nasir M, Trujillo D, Levine J, Dwyer JB, Rupp ZW, Bloch MH. Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology. Frontiers in Psychiatry. 11: 548505. PMID 33329087 DOI: 10.3389/fpsyt.2020.548505 |
0.325 |
|
| 2020 |
Taylor JH, Appel S, Eli M, Alexander-Bloch A, Maayan L, Gur RE, Bloch MH. Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study. Journal of Child and Adolescent Psychopharmacology. PMID 32633541 DOI: 10.1089/Cap.2020.0030 |
0.376 |
|
| 2020 |
Storch EA, Peris TS, De Nadai A, Piacentini J, Bloch M, Cervin M, McGuire J, Farrell LJ, McCracken JT, McKay D, Riemann BC, Wagner AP, Franklin M, Schneider SC, Walkup JT, et al. Little Doubt That CBT Works for Pediatric OCD. Journal of the American Academy of Child and Adolescent Psychiatry. 59: 785-787. PMID 32618273 DOI: 10.1016/J.Jaac.2020.01.026 |
0.379 |
|
| 2020 |
Artukoglu BB, Li F, Szejko N, Bloch MH. Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review. The Journal of Clinical Psychiatry. 81. PMID 32459404 DOI: 10.4088/Jcp.19R12798 |
0.349 |
|
| 2020 |
Farhat LC, Olfson E, Nasir M, Levine JLS, Li F, Miguel EC, Bloch MH. Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta-analysis. Depression and Anxiety. PMID 32390221 DOI: 10.1002/Da.23028 |
0.416 |
|
| 2020 |
Zhou MS, Nasir M, Farhat LC, Kook M, Artukoglu BB, Bloch MH. Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 32387445 DOI: 10.1016/J.Jaac.2020.03.007 |
0.43 |
|
| 2020 |
Dwyer JB, Stringaris A, Brent DA, Bloch MH. Annual Research Review: Defining and treating pediatric treatment-resistant depression. Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 32020643 DOI: 10.1111/Jcpp.13202 |
0.33 |
|
| 2019 |
Li F, Welling MC, Johnson JA, Coughlin C, Mulqueen J, Jakubovski E, Coury S, Landeros-Weisenberger A, Bloch MH. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study. Journal of Child and Adolescent Psychopharmacology. PMID 31800306 DOI: 10.1089/Cap.2019.0041 |
0.421 |
|
| 2019 |
Farhat LC, Olfson E, Levine JLS, Li F, Franklin ME, Lee HJ, Lewin AB, McGuire JF, Rahman O, Storch EA, Tolin DF, Zickgraf HF, Bloch MH. Measuring Treatment Response in Pediatric Trichotillomania: A Meta-Analysis of Clinical Trials. Journal of Child and Adolescent Psychopharmacology. PMID 31794677 DOI: 10.1089/Cap.2019.0103 |
0.33 |
|
| 2019 |
Li F, Nasir M, Olten B, Bloch MH. Meta-analysis of placebo group dropout in adult antidepressant trials. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109777. PMID 31697973 DOI: 10.1016/J.Pnpbp.2019.109777 |
0.405 |
|
| 2019 |
Li F, Nasir M, Olten B, Bloch MH. Meta-Analysis of Placebo Response in Adult Antidepressant Trials. Cns Drugs. PMID 31573058 DOI: 10.1007/S40263-019-00662-Y |
0.34 |
|
| 2019 |
Nasir M, Bloch MH. Trim the fat: the role of omega-3 fatty acids in psychopharmacology. Therapeutic Advances in Psychopharmacology. 9: 2045125319869791. PMID 31489174 DOI: 10.1177/2045125319869791 |
0.42 |
|
| 2019 |
Blanco-Vieira T, Santos M, Ferrão YA, Torres AR, Miguel EC, Bloch MH, Leckman JF, do Rosario MC. The impact of attention deficit hyperactivity disorder in obsessive-compulsive disorder subjects. Depression and Anxiety. PMID 30990937 DOI: 10.1002/Da.22898 |
0.41 |
|
| 2019 |
Artukoglu BB, Bloch MH. The Potential of Cannabinoid-Based Treatments in Tourette Syndrome. Cns Drugs. PMID 30977108 DOI: 10.1007/S40263-019-00627-1 |
0.374 |
|
| 2019 |
Higgins-Chen AT, Abdallah SB, Dwyer JB, Kaye AP, Angarita GA, Bloch MH. Severe Illness Anxiety Treated by Integrating Inpatient Psychotherapy With Medical Care and Minimizing Reassurance. Frontiers in Psychiatry. 10: 150. PMID 30967801 DOI: 10.3389/Fpsyt.2019.00150 |
0.314 |
|
| 2019 |
Dobson ET, Bloch MH, Strawn JR. Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis. The Journal of Clinical Psychiatry. 80. PMID 30753760 DOI: 10.4088/Jcp.17R12064 |
0.383 |
|
| 2019 |
Taylor J, Appel S, Bloch M. F19. TREATMENT RESPONSE OVER THREE RANDOMIZATIONS IN THE TREATMENT OF EARLY-ONSET SCHIZOPHRENIA SPECTRUM DISORDERS STUDY (TEOSS) Schizophrenia Bulletin. 45: S261-S261. DOI: 10.1093/Schbul/Sbz018.431 |
0.367 |
|
| 2019 |
Johnson IN, Shovestul BJ, Niciu MJ, Li F, Bloch MH. 1.60 ANTIDEPRESSANT TREATMENT OF MDD IN PATIENTS WITH COMORBID ALCOHOL USE DISORDER: A META-ANALYSIS OF RANDOMIZED PLACEBO-CONTROLLED TRIALS WITH DISCUSSION OF PEDIATRIC IMPLICATIONS Journal of the American Academy of Child & Adolescent Psychiatry. 58: S166. DOI: 10.1016/J.Jaac.2019.08.082 |
0.407 |
|
| 2019 |
Taylor J, Appel S, Eli M, Bloch MH. 1.4 TIME UNTIL CLINICAL IMPROVEMENT IN THE TREATMENT OF EARLY-ONSET SCHIZOPHRENIA SPECTRUM DISORDERS STUDY (TEOSS) Journal of the American Academy of Child & Adolescent Psychiatry. 58: S148. DOI: 10.1016/J.Jaac.2019.08.026 |
0.375 |
|
| 2019 |
Bloch MH. 44.3 EMERGING AND EVIDENCE-BASED TREATMENTS FOR TIC DISORDERS Journal of the American Academy of Child & Adolescent Psychiatry. 58: S367. DOI: 10.1016/J.Jaac.2019.07.898 |
0.436 |
|
| 2018 |
Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. Depression and Anxiety. PMID 30479005 DOI: 10.1002/Da.22854 |
0.443 |
|
| 2018 |
Farhat LC, Olfson E, Li F, Telang S, Bloch MH. Identifying standardized definitions of treatment response in trichotillomania: A meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30336171 DOI: 10.1016/J.Pnpbp.2018.10.009 |
0.349 |
|
| 2018 |
Banaschewski T, Belsham B, Bloch MH, Ferrin M, Johnson M, Kustow J, Robinson S, Zuddas A. Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD). Nutrition and Health. 260106018772170. PMID 29921155 DOI: 10.1177/0260106018772170 |
0.327 |
|
| 2018 |
Artukoglu BB, Bloch MH. Editorial: Can omega-3 fatty acids improve executive functioning? Will this reduce ADHD and depression? Journal of Child Psychology and Psychiatry, and Allied Disciplines. 59: 615-617. PMID 29808491 DOI: 10.1111/Jcpp.12932 |
0.354 |
|
| 2018 |
Rance M, Walsh C, Sukhodolsky DG, Pittman B, Qiu M, Kichuk SA, Wasylink S, Koller WN, Bloch M, Gruner P, Scheinost D, Pittenger C, Hampson M. Time course of clinical change following neurofeedback. Neuroimage. PMID 29729393 DOI: 10.1016/J.Neuroimage.2018.05.001 |
0.562 |
|
| 2018 |
Bloch M. 33.4 Pharmacological Treatments for Pediatric Trichotillomania Journal of the American Academy of Child & Adolescent Psychiatry. 57: S321. DOI: 10.1016/J.Jaac.2018.07.809 |
0.319 |
|
| 2018 |
Bloch M. 4.3 Advances in the Pharmacological Treatments of Tic Disorders Journal of the American Academy of Child & Adolescent Psychiatry. 57: S275. DOI: 10.1016/J.Jaac.2018.07.637 |
0.45 |
|
| 2017 |
Wilkinson ST, Sanacora G, Bloch MH. Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 327-335. PMID 28989984 DOI: 10.1016/J.Bpsc.2017.01.011 |
0.326 |
|
| 2017 |
Taylor JH, Lebowitz ER, Jakubovski E, Coughlin CG, Silverman WK, Bloch MH. Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 1-16. PMID 28956620 DOI: 10.1080/15374416.2017.1371028 |
0.391 |
|
| 2017 |
Taylor JH, Landeros-Weisenberger A, Coughlin C, Mulqueen J, Johnson JA, Gabriel D, Reed MO, Jakubovski E, Bloch MH. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28849779 DOI: 10.1038/Npp.2017.194 |
0.419 |
|
| 2017 |
Johnson JA, Jakubovski E, Reed MO, Bloch MH. Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 28771386 DOI: 10.1089/Cap.2017.0025 |
0.373 |
|
| 2017 |
van Schalkwyk GI, Beyer C, Johnson J, Deal M, Bloch MH. Antipsychotics for aggression in adults: A meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28754408 DOI: 10.1016/J.Pnpbp.2017.07.019 |
0.365 |
|
| 2017 |
Hirschtritt ME, Bloch MH, Mathews CA. Deep Brain Stimulation for Obsessive-Compulsive Disorder-Reply. Jama. 318: 393. PMID 28742903 DOI: 10.1001/Jama.2017.7873 |
0.342 |
|
| 2017 |
Stuckelman ZD, Mulqueen JM, Ferracioli-Oda E, Cohen SC, Coughlin CG, Leckman JF, Bloch MH. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis. The Journal of Clinical Psychiatry. 78: e648-e655. PMID 28682529 DOI: 10.4088/Jcp.15R10601 |
0.368 |
|
| 2017 |
Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH, Miguel EC, Shavitt RG. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. PMID 28617566 DOI: 10.4088/Jcp.16M11101 |
0.633 |
|
| 2017 |
Gabriel D, Jakubovski E, Taylor JH, Artukoglu BB, Bloch MH. Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study. Psychiatry Research. 255: 248-255. PMID 28595147 DOI: 10.1016/J.Psychres.2017.05.038 |
0.416 |
|
| 2017 |
Bloch MH. Editorial: The continuing contributions of multimodal treatment of attention over nearly two decades to initial attention-deficit hyperactivity disorder pharmacotherapy and long-term clinical course. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 58: 637-639. PMID 28524461 DOI: 10.1111/Jcpp.12755 |
0.384 |
|
| 2017 |
Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment. Jama. 317: 1358-1367. PMID 28384832 DOI: 10.1001/Jama.2017.2200 |
0.434 |
|
| 2017 |
Reed MO, Jakubovski E, Johnson JA, Bloch MH. Predictors of Long-Term School-Based Behavioral Outcomes in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 28253029 DOI: 10.1089/Cap.2015.0168 |
0.358 |
|
| 2017 |
Adams TG, Bloch MH, Pittenger C. Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology. PMID 28121735 DOI: 10.1097/Jcp.0000000000000659 |
0.61 |
|
| 2017 |
Taylor J, Jakubovski E, Gabriel D, Bloch M. M13. Identifying Youths at Risk for Antipsychotic-Induced Weight Gain and Metabolic Dysfunction in the Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) Schizophrenia Bulletin. 43: S215-S216. DOI: 10.1093/Schbul/Sbx022.012 |
0.33 |
|
| 2017 |
Johnson JA, Jakubovski E, Reed MO, Bloch MH. 6.23 Predictors of Long-Term Risky Driving Behavior in the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Journal of the American Academy of Child and Adolescent Psychiatry. 56. DOI: 10.1016/J.Jaac.2017.09.368 |
0.366 |
|
| 2017 |
Dwyer JB, Bloch MH. 2.1 Ketamine As a Treatment for Adolescent Major Depressive Disorder Journal of the American Academy of Child & Adolescent Psychiatry. 56: S176. DOI: 10.1016/J.Jaac.2017.09.081 |
0.377 |
|
| 2017 |
Bloch MH. 6.3 Repetitive Behaviors and Obsessive-Compulsive Symptoms in Autism Spectrum Disorders Journal of the American Academy of Child & Adolescent Psychiatry. 56: S9. DOI: 10.1016/J.Jaac.2017.07.035 |
0.414 |
|
| 2017 |
Dwyer J, Sanacora G, Bloch M. 1002. Ketamine as a Treatment for Adolescent Major Depressive Disorder Biological Psychiatry. 81: S405. DOI: 10.1016/J.Biopsych.2017.02.729 |
0.377 |
|
| 2016 |
Varigonda AL, Jakubovski E, Bloch MH. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 851-859.e2. PMID 27663940 DOI: 10.1016/J.Jaac.2016.07.768 |
0.43 |
|
| 2016 |
Coughlin CG, Jakubovski E, Bloch MH. Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial. The Journal of Clinical Psychiatry. PMID 27631142 DOI: 10.4088/Jcp.15M10075 |
0.357 |
|
| 2016 |
Bloch MH. Commentary: Are alpha-2 agonist really effective in children with tics with comorbid ADHD? A commentary on Whittington et al. (2016). Journal of Child Psychology and Psychiatry, and Allied Disciplines. 57: 1005-7. PMID 27535650 DOI: 10.1111/Jcpp.12592 |
0.363 |
|
| 2016 |
Issaria Y, Jakubovski E, Bartley CA, Pittenger C, Bloch MH. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. The Journal of Clinical Psychiatry. 77: e605-11. PMID 27249090 DOI: 10.4088/Jcp.14R09758 |
0.647 |
|
| 2016 |
Bloch MH, Panza KE, Yaffa A, Alvarenga PG, Jakubovski E, Mulqueen JM, Landeros-Weisenberger A, Leckman JF. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial. Journal of Child and Adolescent Psychopharmacology. PMID 27027204 DOI: 10.1089/Cap.2015.0109 |
0.404 |
|
| 2016 |
Pittenger C, Adams TG, Gallezot JD, Crowley MJ, Nabulsi N, James Ropchan, Gao H, Kichuk SA, Simpson R, Billingslea E, Hannestad J, Bloch M, Mayes L, Bhagwagar Z, Carson RE. OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. Journal of Affective Disorders. 196: 87-96. PMID 26919057 DOI: 10.1016/J.Jad.2016.02.021 |
0.577 |
|
| 2016 |
Schumer MC, Bartley CA, Bloch MH. Systematic Review of Pharmacological and Behavioral Treatments for Skin Picking Disorder. Journal of Clinical Psychopharmacology. PMID 26872117 DOI: 10.1097/Jcp.0000000000000462 |
0.434 |
|
| 2015 |
Lebowitz ER, Panza KE, Bloch MH. Family accommodation in obsessive-compulsive and anxiety disorders: a five year update. Expert Review of Neurotherapeutics. PMID 26613396 DOI: 10.1586/14737175.2016.1126181 |
0.401 |
|
| 2015 |
Jakubovski E, Carlson JP, Bloch MH. Prognostic subgroups for remission, response, and treatment continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) trial. The Journal of Clinical Psychiatry. PMID 26581028 DOI: 10.4088/Jcp.14M09320 |
0.336 |
|
| 2015 |
Jakubovski E, Bloch MH. Anxiety Disorder-Specific Predictors of Treatment Outcome in the Coordinated Anxiety Learning and Management (CALM) Trial. The Psychiatric Quarterly. PMID 26563229 DOI: 10.1007/S11126-015-9399-6 |
0.44 |
|
| 2015 |
Jakubovski E, Varigonda AL, Freemantle N, Taylor MJ, Bloch MH. Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder. The American Journal of Psychiatry. appiajp201515030331. PMID 26552940 DOI: 10.1176/Appi.Ajp.2015.15030331 |
0.407 |
|
| 2015 |
Coughlin CG, Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Bloch MH. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26402485 DOI: 10.1089/Cap.2015.0075 |
0.422 |
|
| 2015 |
Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Coughlin CG, Leckman JF, Bloch MH. Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 728-36. PMID 26299294 DOI: 10.1016/J.Jaac.2015.06.011 |
0.352 |
|
| 2015 |
Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E, Kelmendi B, Sanacora G, Coric V. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial. The Journal of Clinical Psychiatry. 76: 1075-84. PMID 26214725 DOI: 10.4088/Jcp.14M09123 |
0.658 |
|
| 2015 |
Varigonda AL, Jakubovski E, Taylor MJ, Freemantle N, Coughlin C, Bloch MH. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 557-64. PMID 26088660 DOI: 10.1016/J.Jaac.2015.05.004 |
0.396 |
|
| 2015 |
Alvarenga PG, do Rosario MC, Cesar RC, Manfro GG, Moriyama TS, Bloch MH, Shavitt RG, Hoexter MQ, Coughlin CG, Leckman JF, Miguel EC. Obsessive-compulsive symptoms are associated with psychiatric comorbidities, behavioral and clinical problems: a population-based study of Brazilian school children. European Child & Adolescent Psychiatry. PMID 26015374 DOI: 10.1007/S00787-015-0723-3 |
0.391 |
|
| 2015 |
Taylor JH, Jakubovski E, Bloch MH. Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial. Journal of Psychiatric Research. 65: 154-65. PMID 25896121 DOI: 10.1016/J.Jpsychires.2015.03.020 |
0.407 |
|
| 2015 |
Bloch MH, Storch EA. Assessment and management of treatment-refractory obsessive-compulsive disorder in children. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 251-62. PMID 25791142 DOI: 10.1016/J.Jaac.2015.01.011 |
0.438 |
|
| 2015 |
Alvarenga PG, Cesar RC, Leckman JF, Moriyama TS, Torres AR, Bloch MH, Coughlin CG, Hoexter MQ, Manfro GG, Polanczyk GV, Miguel EC, do Rosario MC. Obsessive-compulsive symptom dimensions in a population-based, cross-sectional sample of school-aged children. Journal of Psychiatric Research. 62: 108-14. PMID 25702286 DOI: 10.1016/J.Jpsychires.2015.01.018 |
0.356 |
|
| 2015 |
Kelly JM, Jakubovski E, Bloch MH. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial. The Journal of Clinical Psychiatry. 76: 267-78. PMID 25562579 DOI: 10.4088/Jcp.13M08922 |
0.412 |
|
| 2015 |
Yu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, ... ... Bloch MH, et al. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. The American Journal of Psychiatry. 172: 82-93. PMID 25158072 DOI: 10.1176/Appi.Ajp.2014.13101306 |
0.621 |
|
| 2015 |
Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E, Kelmendi B, Sanacora G, Coric V. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: A pilot randomized placebo-controlled trial Journal of Clinical Psychiatry. 76: 1075-1084. DOI: 10.4088/JCP.14m09123 |
0.33 |
|
| 2014 |
Leckman JF, King RA, Bloch MH. Clinical Features of Tourette Syndrome and Tic Disorders. Journal of Obsessive-Compulsive and Related Disorders. 3: 372-379. PMID 30197854 DOI: 10.1016/J.Jocrd.2014.03.004 |
0.37 |
|
| 2014 |
Bloch MH, Mulqueen J. Nutritional supplements for the treatment of ADHD. Child and Adolescent Psychiatric Clinics of North America. 23: 883-97. PMID 25220092 DOI: 10.1016/J.Chc.2014.05.002 |
0.343 |
|
| 2014 |
Pittenger C, Bloch MH. Pharmacological treatment of obsessive-compulsive disorder. The Psychiatric Clinics of North America. 37: 375-91. PMID 25150568 DOI: 10.1016/J.Psc.2014.05.006 |
0.654 |
|
| 2014 |
Adelman CB, Panza KE, Bartley CA, Bontempo A, Bloch MH. A meta-analysis of computerized cognitive-behavioral therapy for the treatment of DSM-5 anxiety disorders. The Journal of Clinical Psychiatry. 75: e695-704. PMID 25093485 DOI: 10.4088/Jcp.13R08894 |
0.488 |
|
| 2014 |
McGrath LM, Yu D, Marshall C, Davis LK, Thiruvahindrapuram B, Li B, Cappi C, Gerber G, Wolf A, Schroeder FA, Osiecki L, O'Dushlaine C, Kirby A, Illmann C, Haddad S, ... ... Bloch MH, et al. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 910-9. PMID 25062598 DOI: 10.1016/J.Jaac.2014.04.022 |
0.627 |
|
| 2014 |
Bloch MH, Bartley CA, Zipperer L, Jakubovski E, Landeros-Weisenberger A, Pittenger C, Leckman JF. Meta-analysis: hoarding symptoms associated with poor treatment outcome in obsessive-compulsive disorder. Molecular Psychiatry. 19: 1025-30. PMID 24912494 DOI: 10.1038/Mp.2014.50 |
0.655 |
|
| 2014 |
Jakubovski E, Bloch MH. Prognostic subgroups for citalopram response in the STAR*D trial. The Journal of Clinical Psychiatry. 75: 738-47. PMID 24912106 DOI: 10.4088/Jcp.13M08727 |
0.428 |
|
| 2014 |
Bloch MH. Meta-analysis and moderator analysis: can the field develop further? Journal of the American Academy of Child and Adolescent Psychiatry. 53: 135-7. PMID 24472248 DOI: 10.1016/J.Jaac.2013.12.001 |
0.413 |
|
| 2014 |
Castellan Baldan L, Williams KA, Gallezot JD, Pogorelov V, Rapanelli M, Crowley M, Anderson GM, Loring E, Gorczyca R, Billingslea E, Wasylink S, Panza KE, Ercan-Sencicek AG, Krusong K, Leventhal BL, ... ... Bloch MH, et al. Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice. Neuron. 81: 77-90. PMID 24411733 DOI: 10.1016/J.Neuron.2013.10.052 |
0.657 |
|
| 2014 |
Anticevic A, Hu S, Zhang S, Savic A, Billingslea E, Wasylink S, Repovs G, Cole MW, Bednarski S, Krystal JH, Bloch MH, Li CS, Pittenger C. Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biological Psychiatry. 75: 595-605. PMID 24314349 DOI: 10.1016/J.Biopsych.2013.10.021 |
0.576 |
|
| 2014 |
Fritzen FM, Bloch MH. N-acetylcysteine for the treatment of obsessive-compulsive disorder Current Psychiatry Reviews. 10: 308-316. DOI: 10.2174/1573400510666140807005327 |
0.504 |
|
| 2014 |
Bloch MH, Lennington JB, Szuhay G, Lombroso PJ. Obsessive-Compulsive Disorder Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. 1301-1310. DOI: 10.1016/B978-0-12-410529-4.00106-6 |
0.303 |
|
| 2013 |
Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, ... Bloch MH, et al. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. Plos Genetics. 9: e1003864. PMID 24204291 DOI: 10.1371/Journal.Pgen.1003864 |
0.594 |
|
| 2013 |
Sukhodolsky DG, Bloch MH, Panza KE, Reichow B. Cognitive-behavioral therapy for anxiety in children with high-functioning autism: a meta-analysis. Pediatrics. 132: e1341-50. PMID 24167175 DOI: 10.1542/Peds.2013-1193 |
0.413 |
|
| 2013 |
Bartley CA, Bloch MH. Meta-analysis: pharmacological treatment of pathological gambling. Expert Review of Neurotherapeutics. 13: 887-94. PMID 23952195 DOI: 10.1586/14737175.2013.814938 |
0.366 |
|
| 2013 |
Niciu MJ, Grunschel BD, Corlett PR, Pittenger C, Bloch MH. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder. Journal of Psychopharmacology (Oxford, England). 27: 651-4. PMID 23676198 DOI: 10.1177/0269881113486718 |
0.64 |
|
| 2013 |
Bartley CA, Hay M, Bloch MH. Meta-analysis: aerobic exercise for the treatment of anxiety disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 45: 34-9. PMID 23643675 DOI: 10.1016/J.Pnpbp.2013.04.016 |
0.339 |
|
| 2013 |
Bloch MH, Green C, Kichuk SA, Dombrowski PA, Wasylink S, Billingslea E, Landeros-Weisenberger A, Kelmendi B, Goodman WK, Leckman JF, Coric V, Pittenger C. Long-term outcome in adults with obsessive-compulsive disorder. Depression and Anxiety. 30: 716-22. PMID 23532944 DOI: 10.1002/da.22103 |
0.585 |
|
| 2013 |
Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 43: 2435-41. PMID 23468071 DOI: 10.1007/S10803-013-1793-Z |
0.407 |
|
| 2013 |
Panza KE, Pittenger C, Bloch MH. Age and gender correlates of pulling in pediatric trichotillomania. Journal of the American Academy of Child and Adolescent Psychiatry. 52: 241-9. PMID 23452681 DOI: 10.1016/J.Jaac.2012.12.019 |
0.601 |
|
| 2013 |
Bloch MH, Panza KE, Grant JE, Pittenger C, Leckman JF. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. Journal of the American Academy of Child and Adolescent Psychiatry. 52: 231-40. PMID 23452680 DOI: 10.1016/J.Jaac.2012.12.020 |
0.606 |
|
| 2013 |
Kichuk SA, Torres AR, Fontenelle LF, Rosário MC, Shavitt RG, Miguel EC, Pittenger C, Bloch MH. Symptom dimensions are associated with age of onset and clinical course of obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 44: 233-9. PMID 23410525 DOI: 10.1016/J.Pnpbp.2013.02.003 |
0.598 |
|
| 2013 |
Cohen SC, Leckman JF, Bloch MH. Clinical assessment of Tourette syndrome and tic disorders. Neuroscience and Biobehavioral Reviews. 37: 997-1007. PMID 23206664 DOI: 10.1016/J.Neubiorev.2012.11.013 |
0.446 |
|
| 2013 |
Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH. Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neuroscience and Biobehavioral Reviews. 37: 1162-71. PMID 23099282 DOI: 10.1016/J.Neubiorev.2012.09.008 |
0.377 |
|
| 2013 |
Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Davis LK, Osiecki L, McGrath L, Haddad S, Crane J, Hezel D, ... ... Bloch M, et al. Genome-wide association study of obsessive-compulsive disorder. Molecular Psychiatry. 18: 788-98. PMID 22889921 DOI: 10.1038/Mp.2012.85 |
0.566 |
|
| 2013 |
Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Osiecki L, McGrath L, Haddad S, Crane J, Hezel D, Illman C, ... ... Bloch M, et al. Erratum: Genome-wide association study of obsessive-compulsive disorder Molecular Psychiatry. 18: 843-843. DOI: 10.1038/Mp.2013.15 |
0.567 |
|
| 2012 |
Bloch MH, Wasylink S, Landeros-Weisenberger A, Panza KE, Billingslea E, Leckman JF, Krystal JH, Bhagwagar Z, Sanacora G, Pittenger C. Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biological Psychiatry. 72: 964-70. PMID 22784486 DOI: 10.1016/J.Biopsych.2012.05.028 |
0.626 |
|
| 2012 |
Bontempo A, Panza KE, Bloch MH. D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis. The Journal of Clinical Psychiatry. 73: 533-7. PMID 22579153 DOI: 10.4088/Jcp.11R07356 |
0.424 |
|
| 2012 |
Carrasco M, Volkmar FR, Bloch MH. Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics. 129: e1301-10. PMID 22529279 DOI: 10.1542/Peds.2011-3285 |
0.415 |
|
| 2012 |
Gray SM, Bloch MH. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Current Psychiatry Reports. 14: 220-8. PMID 22477442 DOI: 10.1007/S11920-012-0272-0 |
0.308 |
|
| 2012 |
Chalita PJ, Palacios L, Cortes JF, Landeros-Weisenberger A, Panza KE, Bloch MH. Relationship of dropout and psychopathology in a high school sample in Mexico. Frontiers in Psychiatry. 3: 20. PMID 22419912 DOI: 10.3389/Fpsyt.2012.00020 |
0.313 |
|
| 2012 |
Lebowitz ER, Panza KE, Su J, Bloch MH. Family accommodation in obsessive-compulsive disorder. Expert Review of Neurotherapeutics. 12: 229-38. PMID 22288678 DOI: 10.1586/Ern.11.200 |
0.376 |
|
| 2012 |
Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Molecular Psychiatry. 17: 1272-82. PMID 21931319 DOI: 10.1038/Mp.2011.100 |
0.373 |
|
| 2012 |
Bloch MH, Hannestad J. Response to critiques on Omega-3 fatty acids for the treatment of depression: Systematic review and meta-analysis Molecular Psychiatry. 17: 1163-1167. DOI: 10.1038/Mp.2012.116 |
0.302 |
|
| 2011 |
Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacology & Therapeutics. 132: 314-32. PMID 21963369 DOI: 10.1016/J.Pharmthera.2011.09.006 |
0.744 |
|
| 2011 |
Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry. 50: 991-1000. PMID 21961774 DOI: 10.1016/J.Jaac.2011.06.008 |
0.341 |
|
| 2011 |
Jakubovski E, Pittenger C, Torres AR, Fontenelle LF, do Rosario MC, Ferrão YA, de Mathis MA, Miguel EC, Bloch MH. Dimensional correlates of poor insight in obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1677-81. PMID 21640153 DOI: 10.1016/J.Pnpbp.2011.05.012 |
0.656 |
|
| 2011 |
Bloch M, State M, Pittenger C. Recent advances in Tourette syndrome Current Opinion in Neurology. 24: 119-125. PMID 21386676 DOI: 10.1097/Wco.0B013E328344648C |
0.605 |
|
| 2011 |
Bloch MH, Sukhodolsky DG, Dombrowski PA, Panza KE, Craiglow BG, Landeros-Weisenberger A, Leckman JF, Peterson BS, Schultz RT. Poor fine-motor and visuospatial skills predict persistence of pediatric-onset obsessive-compulsive disorder into adulthood. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 52: 974-83. PMID 21244423 DOI: 10.1111/J.1469-7610.2010.02366.X |
0.38 |
|
| 2011 |
Reyes MM, Panza KE, Martin A, Bloch MH. Time-lag bias in trials of pediatric antidepressants: a systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry. 50: 63-72. PMID 21156271 DOI: 10.1016/J.Jaac.2010.10.008 |
0.35 |
|
| 2011 |
Palermo SD, Bloch MH, Craiglow B, Landeros-Weisenberger A, Dombrowski PA, Panza K, Smith ME, Peterson BS, Leckman JF. Predictors of early adulthood quality of life in children with obsessive-compulsive disorder. Social Psychiatry and Psychiatric Epidemiology. 46: 291-7. PMID 20191262 DOI: 10.1007/S00127-010-0194-2 |
0.357 |
|
| 2010 |
Bloch MH, Pittenger C. The Genetics of Obsessive-Compulsive Disorder. Current Psychiatry Reviews. 6: 91-103. PMID 23970845 DOI: 10.2174/157340010791196439 |
0.635 |
|
| 2010 |
Leckman JF, Bloch MH, Smith ME, Larabi D, Hampson M. Neurobiological substrates of Tourette's disorder. Journal of Child and Adolescent Psychopharmacology. 20: 237-47. PMID 20807062 DOI: 10.1089/Cap.2009.0118 |
0.375 |
|
| 2010 |
Landeros-Weisenberger A, Bloch MH, Kelmendi B, Wegner R, Nudel J, Dombrowski P, Pittenger C, Krystal JH, Goodman WK, Leckman JF, Coric V. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. Journal of Affective Disorders. 121: 175-9. PMID 19577308 DOI: 10.1016/J.Jad.2009.06.010 |
0.646 |
|
| 2010 |
Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry. 15: 850-5. PMID 19468281 DOI: 10.1038/Mp.2009.50 |
0.641 |
|
| 2009 |
Bloch MH, Leckman JF. Clinical course of Tourette syndrome. Journal of Psychosomatic Research. 67: 497-501. PMID 19913654 DOI: 10.1016/J.Jpsychores.2009.09.002 |
0.446 |
|
| 2009 |
Bloch MH, Craiglow BG, Landeros-Weisenberger A, Dombrowski PA, Panza KE, Peterson BS, Leckman JF. Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics. 124: 1085-93. PMID 19786445 DOI: 10.1542/Peds.2009-0015 |
0.423 |
|
| 2009 |
Bloch MH. Trichotillomania across the life span. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 879-83. PMID 19692854 DOI: 10.1097/Chi.0B013E3181Ae09F3 |
0.442 |
|
| 2009 |
Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 884-93. PMID 19625978 DOI: 10.1097/Chi.0B013E3181B26E9F |
0.415 |
|
| 2009 |
Bloch MH. Clinical Handbook of Obsessive-Compulsive Disorder and Related Problems The Journal of Clinical Psychiatry. 70: 608-609. DOI: 10.4088/Jcp.08Bk04944 |
0.375 |
|
| 2008 |
Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive-compulsive disorder. The American Journal of Psychiatry. 165: 1532-42. PMID 18923068 DOI: 10.1176/Appi.Ajp.2008.08020320 |
0.596 |
|
| 2008 |
Leckman JF, Bloch MH. A developmental and evolutionary perspective on obsessive-compulsive disorder: whence and whither compulsive hoarding? The American Journal of Psychiatry. 165: 1229-33. PMID 18829875 DOI: 10.1176/Appi.Ajp.2008.08060891 |
0.418 |
|
| 2008 |
Pittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G. Riluzole in the treatment of mood and anxiety disorders. Cns Drugs. 22: 761-86. PMID 18698875 DOI: 10.2165/00023210-200822090-00004 |
0.669 |
|
| 2008 |
Bloch MH. Emerging treatments for Tourette's disorder. Current Psychiatry Reports. 10: 323-30. PMID 18627671 DOI: 10.1007/S11920-008-0052-Z |
0.461 |
|
| 2008 |
Pittenger C, Kelmendi B, Wasylink S, Bloch MH, Coric V. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up. Journal of Clinical Psychopharmacology. 28: 363-7. PMID 18480706 DOI: 10.1097/Jcp.0B013E3181727548 |
0.642 |
|
| 2008 |
Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 850-8. PMID 18186076 DOI: 10.1002/Ajmg.B.30699 |
0.605 |
|
| 2008 |
Bloch MH, Landeros-Weisenberger A, Dombrowski P, Nudel J, Pittenger C, Leckman JF, Kelmendi B, Wegner R, Coric V. Response to Chamberlain et al. Re: Systematic Review: Pharmacological and Behavioral Treatments for Trichotillomania Biological Psychiatry. 63: e34-e35. DOI: 10.1016/J.Biopsych.2008.01.022 |
0.54 |
|
| 2008 |
Bloch MH. Emerging treatment for Tourette's disorder Current Psychiatry Reports. 10: 323-330. DOI: 10.1007/s11920-008-0052-z |
0.307 |
|
| 2007 |
Bloch MH, Landeros-Weisenberger A, Dombrowski P, Kelmendi B, Wegner R, Nudel J, Pittenger C, Leckman JF, Coric V. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biological Psychiatry. 62: 839-46. PMID 17727824 DOI: 10.1016/J.Biopsych.2007.05.019 |
0.603 |
|
| 2007 |
Coric V, Kelmendi B, Pittenger C, Wasylink S, Bloch MH, Green J. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania. The Journal of Clinical Psychiatry. 68: 170-1. PMID 17284151 DOI: 10.4088/Jcp.V68N0123F |
0.523 |
|
| 2006 |
Leckman JF, Bloch MH, Scahill L, King RA. Tourette syndrome: the self under siege. Journal of Child Neurology. 21: 642-9. PMID 16970864 DOI: 10.1177/08830738060210081001 |
0.374 |
|
| 2006 |
Bloch MH, Sukhodolsky DG, Leckman JF, Schultz RT. Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 47: 551-9. PMID 16712631 DOI: 10.1111/J.1469-7610.2005.01561.X |
0.311 |
|
| 2006 |
Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry. 11: 622-32. PMID 16585942 DOI: 10.1038/Sj.Mp.4001823 |
0.473 |
|
| 2006 |
Bloch MH, Peterson BS, Scahill L, Otka J, Katsovich L, Zhang H, Leckman JF. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Archives of Pediatrics & Adolescent Medicine. 160: 65-9. PMID 16389213 DOI: 10.1001/Archpedi.160.1.65 |
0.404 |
|
| 2006 |
Bloch M. Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders: Second Edition Journal of the American Academy of Child & Adolescent Psychiatry. 45: 494-495. DOI: 10.1097/01.Chi.0000199022.38334.A7 |
0.366 |
|
| 2006 |
Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. Erratum: A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder Molecular Psychiatry. 11: 795-795. DOI: 10.1038/sj.mp.4001859 |
0.345 |
|
| 2005 |
Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology. 65: 1253-8. PMID 16247053 DOI: 10.1212/01.Wnl.0000180957.98702.69 |
0.36 |
|
| Show low-probability matches. |